Phylos Bioscience has filed a notice of an exempt offering of securities to raise $4,518,519.00 in Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Phylos Bioscience is raising $4,518,519.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Dylan Anderson played a key role in…